Original Article
Oncogene (2007) 26, 7153–7157; doi:10.1038/sj.onc.1210509; published online 7 May 2007
Reprogramming of the SWI/SNF complex for co-activation or co-repression in prohibitin-mediated estrogen receptor regulation
B Zhang1, K J Chambers1, D V Faller1 and S Wang1
1Cancer Research Center, Boston University School of Medicine, Boston, MA, USA
Correspondence: Professor S Wang, Cancer Research Center, R-906, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118, USA. E-mail: sw184@bu.edu
Received 21 December 2006; Revised 23 March 2007; Accepted 1 April 2007; Published online 7 May 2007.
Abstract
The SWI/SNF complex participates as a co-activator in the transcriptional regulation of certain genes. Conversely, we and others have recently established that Brg1 and Brm, the central components of SWI/SNF, act instead as co-repressors for E2F-mediated transcriptional repression, and for the transcription of certain other promoters. We report here that Brg-1 and Brm can switch their mode of function at same promoter between activation and repression by ligand-directed differential coordination with BAF155, BAF170, HDAC1, p300 and prohibitin. This ligand and context-dependent reprogramming of the SWI/SNF complex allows it to differentially serve as either a co-repressor or a co-activator of transcription at the same promoter.
Keywords:
ER, prohibitin, Brg1, Brm, HDAC, HAT
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
NEWS AND VIEWS
Second messenger control of chromatin remodeling
Nature Structural Biology News and Views (01 Feb 2003)
Nature Genetics News and Views (01 Mar 2005)
RESEARCH
Oncogene Original Article
Oncogene Original Article
